In patients with pulmonary hypertension, PDE5 inhibitors significantly improve cardiac index (mean difference: 0.18, 95% CI: 0.04, 0.32, p-value: 0.01), as shown in Figure 3. This evidence concerns the gene PDE5A and pulmonary arterial hypertension.